Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid
Journal of Surgical Oncology · 2026
DOI: 10.1002/jso.70292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2026. Verfasst von Krystal Mills und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, DNA Methylation, Biomarkers, Tumor, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Exact Sciences (Madison, WI) Provided Critical Assay Reagents, Centene Foundation (to Dr. Majumder).
Abstract (Originalsprache)
Background and Objectives Occult intra‐abdominal metastases are identified in approximately 20% of patients with radiographically localized pancreatic ductal adenocarcinoma (PDAC) through staging laparoscopy, as peritoneal cytology is limited in sensitivity. Methylated DNA markers (MDMs) have demonstrated high diagnostic accuracy for PDAC in tumor tissue, blood, and pancreatic secretions. This study assesses the feasibility and diagnostic performance of MDMs in peritoneal lavage fluid collected during staging laparoscopy, comparing their performance to mutant KRAS (m KRAS ) detection.
Methods
DNA from peritoneal lavage fluid of PDAC patients was analyzed for m KRAS mutations (codons 12, 13, and 61) using droplet‐digital PCR and for 13 MDMs and a reference gene (B3GALT6) using quantitative methylation‐specific PCR. An MDM score was generated from the average signal of the 13 MDMs and evaluated for its ability to detect intra‐abdominal metastases via receiver operator characteristic (ROC) analysis.
Results
Among 48 patients, 15 (31%) had intra‐abdominal metastases. The MDM score showed 87% sensitivity and 90% specificity (AUC = 0.98), outperforming m KRAS , which showed 40% sensitivity and 85% specificity (AUC = 0.62; p < 0.0001).
Conclusions
MDMs in peritoneal lavage fluid may enable highly accurate molecular staging of PDAC and warrant validation in larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Travis E Grotz
Förderung
- NCI NIH HHS
- Exact Sciences (Madison, WI) Provided Critical Assay Reagents
- Centene Foundation (to Dr. Majumder)
Zitieren
APA
Mills, K., Berger, C. K., Taylor, W. R., Mahoney, D. W., Burger, K. N., Maheshwari, K., Kipp, B. R., Delgado, A. M., Doering, K. A., Streich, H. M., Foote, P. H., Cleary, S. P., Grotz, T. E., Kendrick, M. L., Smoot, R. L., Starlinger, P. P., Thiels, C. A., Truty, M. J., Warner, S. G., …, & Majumder, S. (2026). Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70292
Vancouver
Mills K, Berger CK, Taylor WR, Mahoney DW, Burger KN, Maheshwari K, et al. Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70292
BibTeX
@article{Mills2026,
author = {Mills, Krystal and Berger, Calise K and Taylor, William R and Mahoney, Douglas W and Burger, Kelli N and Maheshwari, Kalika and Kipp, Benjamin R and Delgado, Adriana M and Doering, Karen A and Streich, Heather M and Foote, Patrick H and Cleary, Sean P and Grotz, Travis E and Kendrick, Micheal L and Smoot, Rory L and Starlinger, Patrick P and Thiels, Cornelius A and Truty, Mark J and Warner, Susanne G and Kisiel, John B and Majumder, Shounak},
title = {Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid},
journal = {Journal of Surgical Oncology},
year = {2026},
doi = {10.1002/jso.70292}
}
EUVIMED